$49.76
+0.21 (+0.42%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+25.4% upside
Low Target
$43.17
Average Target
$62.39
High Target
$72.87
Current Price
$49.76
Current
$49.76
$49.76
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Scenario Analysis
Bear Case
$43.17
-13.2%
Low target
Base Case
$62.39
+25.4%
Avg target
Bull Case
$72.87
+46.4%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$59.30
-16.1% from high
52-Week Low
$25.28
+96.8% from low
50-Day SMA
$30.02
+65.8% vs SMA
200-Day SMA
$32.89
+51.3% vs SMA
RSI (14)
46.3
Neutral
Target vs 52W High
$62.39
+5.2% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $0.34
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |